Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1100
0.00 (0.00%)
At close: Oct 6, 2026

Invex Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
87751537
Market Cap Growth
-8.33%1.12%48.33%-70.00%-59.60%-21.43%
Enterprise Value
421-2-106
Last Close Price
0.110.090.090.060.050.13

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
176.55144.4529.203.7232.74204.12
PB Ratio
2.111.731.270.790.711.31
P/TBV Ratio
2.111.731.270.790.711.31

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
90.7846.313.85--32.02

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-1.03-1.03-1.02-1.06-1.06-1.03
Asset Turnover
0.010.010.040.080.020.01
Quick Ratio
26.4826.4824.7914.1814.5029.36
Current Ratio
26.4826.4824.7914.1814.5029.36
Return on Equity (ROE)
-29.54%-29.54%-8.72%-12.20%-31.18%-13.05%
Return on Assets (ROA)
-19.64%-19.64%-7.65%-9.22%-20.43%-8.10%
Return on Capital Employed (ROCE)
-38.30%-38.30%-13.50%-37.50%-40.30%-14.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-16.36%-19.99%-7.13%-36.41%-51.56%-10.63%
Buyback Yield / Dilution
0.74%0.74%-0.51%-0.19%-0.02%-0.03%